Literature DB >> 30626229

Transmembrane G protein-coupled receptor 30 gene polymorphisms and uterine adenomyosis in Korean women.

Dae Gy Hong1, Ji Young Park2, Gun Oh Chong1, Yoon Hee Lee1, Hyun Jung Lee3, Jung Un Shinn1, Yoon Soon Lee1, Won Joon Seong1.   

Abstract

To compare the genetic distributions of 14G protein-coupled receptor 30 (GPR30) single-nucleotide polymorphisms (SNPs) between women with and without uterine adenomyosis. The study population comprised 69 Korean women. Uterine tissues from the adenomyosis and non-adenomyosis groups were used for DNA extraction. Pre-designed PCR/Sanger or Sequencing Primer and TaqMan® SNP Genotyping Assays were used for the SNP genotyping of the GPR30 gene. Immunohistochemical staining was performed to confirm the GPR30 expression. Differences in genotype and allele frequencies between the two groups were calculated using Fisher's exact test. The rs3802141 CT genotype was more common in the control group (p = .02), and the rs4266553 CC genotype was more common in the adenomyosis group (p = .02). The C allele of the SNP rs4266553 was more common in the adenomyosis group (p = .02). GPR30 expression was confirmed in 69 individuals in both groups. GPR30 gene polymorphism is presumed to affect the risk of adenomyosis with limited sample size. Further large-scale study is needed to explain the genetic influence of GPR30 gene polymorphism.

Entities:  

Keywords:  Adenomyosis; G protein-coupled receptor 30; single-nucleotide polymorphism

Year:  2019        PMID: 30626229     DOI: 10.1080/09513590.2018.1540572

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  4 in total

1.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

2.  Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression.

Authors:  Zulvikar Syambani Ulhaq; Gita Vita Soraya; Alvi Milliana; William Ka Fai Tse
Journal:  Heliyon       Date:  2021-03-10

Review 3.  Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A Perspective.

Authors:  Radhashree Maitra; Parth Malik; Tapan Kumar Mukherjee
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

4.  Integrating Network Pharmacology and Experimental Validation Deciphers the Mechanism of Guizhi Fuling Wan against Adenomyosis.

Authors:  Haoxian Wang; Jihong Zhang; Qinqin Zhu; Xianyun Fu; Chenjie Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-26       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.